Beyond the Budget: The New Grant Landscape
Author: Joel Spotswood
The recent 2026-27 Federal Budget was one of the most significant in recent memory, announcing reforms and changes to established economic programs and schemes in the name of long-term economic resilience. Following our immediate takeaways from the 2026-27 Budget, Intellect Labs’s Beyond the Budget series will dive into specific areas of the budget announcements to analyse the immediate impacts and advise the long-term takeaways for Australian businesses and SMEs.
Today’s edition focusses on the impact of the budget on innovation funding via competitive grant programs.
Alongside capital raising, accessing grant funding through state and national schemes can be critical for innovative start-ups and SMEs. Stacked with the R&D Tax Incentive and targeted loan facilities through programs such as the NRF, grants form the backbone of a company’s non-dilutive funding strategy and pipeline, which can fasttrack R&D, attract and leverage investment, foster critical collaborations and accelerate commercialisation.
The challenges with grant funding are shifting deadlines, long decision-making timelines and high competition. Thus, it’s vital for a business to stay across the innovation funding landscape and maintain a long-term grant strategy. Over the past 12 months, we have reviewed and observed a number of Australia’s flagship programs for funding innovation in critical priority areas; including the IGP, CRC-P and MRFF. Some key observations have been silently dwindling pools of funds, increased competition and burgeoning uncertainty regarding the availability of significant, long-term innovation funding (via grants) at the federal level.
Grant Program Updates
Industry Growth Program (IGP): the future of Australia’s flagship program for supporting commercialisation was already uncertain before the budget with $102M in uncommitted funding cut in the Mid-Year Economic and Fiscal Outlook. This was compounded in the budget announcement, with an additional $47.4M of program funding being redirected over forward estimates and in the ensuing days, the program pausing new applications.
While the pause is for active program review rather than being cancelled outright, the combination of depleted original funding, redirected uncommitted funds, and the absence of a confirmed new funding round means the near-term pipeline for new grant applicants is effectively closed.
Furthermore, an additional $162.M of uncommitted grant funding was cut from the DISR budget. While not related to the IGP directly, it is another signal that the government is looking to redirect innovation support away from direct grant funding.
Australian Economic Accelerator (AEA): the popular AEA program has effectively been wound down. The government confirmed that no new research projects will be funded through the AEA beyond the 2025-26 financial year, with existing AEA Ignite and Innovate grants honoured through to completion but no further rounds opening. For the university-industry partnerships that relied on AEA as a stage-gated pathway from proof-of-concept to commercialisation, this closes off a $1.6 billion program that was specifically designed to bridge that gap. Businesses that have leaned on AEA-linked university partners for translation funding will need to look elsewhere, as the program joins the IGP in moving from open to closed within the same budget cycle.
Cooperative Research Centres (CRC) Program: the CRC Program emerged from this budget cycle intact, but with a narrowed focus. CRC-P Round 19 closed in May with $20M earmarked specifically for AI-enabled projects as part of the government's broader AI Accelerator initiative, while the longer-term CRC Grants stream has a dedicated Round 28 "AI Accelerator" round flagged for 2027, worth approximately $50M. With the winding down of the AEA program, the CRC-P remains one of the only direct paths to matched grant funding for industry-research collaborations. The trade-off is that prospective applicants may find future rounds more competitive.
Medical Research Future Fund (MRFF): as we flagged before the budget, the MRFF had been distributing roughly half its $1 billion annual target for years, despite a swelling capital base. The 2026-27 budget saw the commitment of $500M+ in additional MRFF disbursements over four years, lifting annual distributions to a stated target of $1 billion by 2030-31.
For SMEs and businesses, its important to note that MRFF funding isn't restricted to universities and research institutes. Private companies are eligible to apply, provided they meet the relevant program criteria, yet privately-led bids have historically been underrepresented among successful grants. With the IGP and AEA pipelines both effectively closed, businesses operating in the health and medical space, particularly those with strong existing connections across the health and research community, should be considering the MRFF as part of a diversified grant funding pipeline.
Export Market Development Grants (EMDG): The budget papers confirm the EMDG program continues, with forward estimates holding funding at $110M per year through to 2029-30. What isn't yet settled is the shape of Round 5, which will cover the 2027-28 and 2028-29 financial years: tier thresholds, eligible expenditure categories and assessment criteria are all still pending the outcome of the program review. Applications for Round 5 are expected to open around November 2026, mirroring the Round 4 timeline.
The Takeaway
The pattern emerging across MYEFO and the 2026-27 Federal Budget is a shift toward concentration of existing grant funding programs: where funding remains committed, it's increasingly tied either to a specific strategic priority or to a program structure under review or redesign. For businesses and SMEs that have built grant funding into their non-dilutive capital strategy, the practical implication is that a credible grant strategy now needs to account for a sharper alignment with government priority areas, and closer attention to the fine print of programs still in transition.
Despite the contraction in grant funding, the government has continued to publicly commit to supporting innovation and start-ups as a policy priority. What remains unclear is what mechanism that commitment will ultimately take. Whether this represents a temporary pause while programs are reviewed and redesigned, or a more permanent pivot away from direct competitive grants toward incentive-based or market-driven mechanisms such as tax-incentives and loan schemes, remains to be seen. We'll continue tracking each of these programs as new rounds, reviews and reallocations are announced.